Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/2454
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Baris, Elif | - |
dc.contributor.author | Arici, M. Aylin | - |
dc.date.accessioned | 2023-06-16T14:40:43Z | - |
dc.date.available | 2023-06-16T14:40:43Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 2458-8938 | - |
dc.identifier.issn | 2564-7288 | - |
dc.identifier.uri | https://doi.org/10.30621/jbachs.869857 | - |
dc.identifier.uri | https://search.trdizin.gov.tr/yayin/detay/436595 | - |
dc.identifier.uri | https://hdl.handle.net/20.500.14365/2454 | - |
dc.description.abstract | Severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) or coronavirus infectious disease (COVID-19) outbreak is continued to spread all over the world recently with the high mortality and morbidity rates. It is also known well COVID-19 is leading causes of acute lung injury and acute respiratory distress syndrome (ARDS), sepsis and multiorgan failure. Current treatment of COVID-19, includes different strategies targeting preventing viral replication or treating secondary infections and decreasing exaggerated immune response. Although antiviral, antimicrobial, immunomodulatory agents including anti-cytokines and glucocorticoids have been currently applied, there is lack of a specific treatment for COVID-19. In this review, possible therapeutic roles of cholinomimetic drugs in the control of COVID-19 related inflammation is discussed. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Dokuz Eylul Univ Inst Health Sciences | en_US |
dc.relation.ispartof | Journal of Basıc And Clınıcal Health Scıences | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Cholinomimetic drugs | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | Cytokine Storm | en_US |
dc.subject | Vagus Nerve | en_US |
dc.subject | Nicotine | en_US |
dc.subject | Endotoxin | en_US |
dc.title | POSSIBLE THERAPEUTIC ROLE OF CHOLINERGIC AGONISTS ON COVID-19 RELATED INFLAMMATORY RESPONSE | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.30621/jbachs.869857 | - |
dc.department | İzmir Ekonomi Üniversitesi | en_US |
dc.identifier.volume | 5 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 102 | en_US |
dc.identifier.endpage | 108 | en_US |
dc.identifier.wos | WOS:000701322900016 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.trdizinid | 436595 | en_US |
item.grantfulltext | open | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | With Fulltext | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | 09.01. Basic Medical Sciences | - |
Appears in Collections: | TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.